HomeSYRS • OTCMKTS
Syros Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.66M | -27.16% |
Net income | -6.40M | 84.07% |
Net profit margin | — | — |
Earnings per share | -0.16 | 88.15% |
EBITDA | -25.86M | 18.35% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.28M | -48.07% |
Total assets | 85.00M | -42.49% |
Total liabilities | 96.12M | -13.79% |
Total equity | -11.12M | — |
Shares outstanding | 26.83M | — |
Price to book | -0.08 | — |
Return on assets | -68.28% | — |
Return on capital | -126.59% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.40M | 84.07% |
Cash from operations | -20.69M | 35.06% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -20.69M | -541.92% |
Free cash flow | -11.00M | 45.93% |
Previous close
$0.032
Day range
$0.030 - $0.039
Year range
$0.015 - $0.10
Market cap
993.42K USD
Avg Volume
208.24K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2011
Website
Employees
68
